Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer

Clinical Trial ID NCT01216527

Rank	Title	Journal	Year	PubWeight™‹?›
1	Global cancer statistics.	CA Cancer J Clin	2011	185.92
2	Preoperative chemoradiotherapy for esophageal or junctional cancer.	N Engl J Med	2012	15.43
3	Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.	Ann Oncol	2014	0.91
4	Esophageal carcinoma advances in treatment results for locally advanced disease: review.	Ann Oncol	2011	0.88
5	Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma.	Med Oncol	2003	0.88
6	Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status.	Anticancer Res	2008	0.85
7	A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma.	Cancer Invest	2006	0.79
8	New and emerging combination therapies for esophageal cancer.	Cancer Manag Res	2013	0.77
9	[Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma].	Zhonghua Yi Xue Za Zhi	2008	0.75